Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1) Is Required for Branching Morphogenesis in the Chorioallantoic Placenta

REFERENCES

• Adams, R. H., A. Porras, G. Alonso, M. Jones, K. Vintersten, S. Panelli, A. Valladares, L. Perez, R. Klein, and A. R. Nebreda. 2000. Essential Role of p38α MAP kinase in placental but not embryonic cardiovascular development. Mol. Cell 6:109–116.
   PubMed Web of Science ®Google Scholar
• Anson-Cartwright., L., K. Dawson, D. Holmyard, S. J. Fisher, R. A. Lazzarini, and J. C. Cross. 2000. The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta. Nat. Genet. 25:311–314.
   PubMed Web of Science ®Google Scholar
• Baczyk, D., A. Satkunaratnam, B. Nait-Oumensmar, B. Huppertz, J. C. Cross, and J. C. P. Kingdom. 2004. Complex patterns of GCM1 mRNA and protein in villous and extravillous trophoblast cells of the human placenta. Placenta 25:553–559.
   PubMed Web of Science ®Google Scholar
• Barak, Y., M. C. Nelson, E. S. Ong, Y. Z. Jones, P. Ruiz-Lozano, K. R. Chien, A. Koder, and R. M. Evans. 1999. PPARγ is required for placental, cardiac, and adipose tissue development. Mol. Cell 4:585–595.
   PubMed Web of Science ®Google Scholar
• Bladt, F., D. Reithmacher, S. Isenmann, A. Aguzzi, and C. Birchmeier. 1995. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376:768–771.
   PubMed Web of Science ®Google Scholar
• Colosi, P., F. Talamantes, and D. I. Linzer. 1987. Molecular cloning and expression of mouse placental lactogen I complementary deoxyribonucleic acid. Mol. Endocrinol. 1:767–776.
   PubMedGoogle Scholar
• Ihle, J. N. 2000. The challenges of translating knockout phenotype into gene function. Cell 102:131–134.
   PubMedGoogle Scholar
• Itoh, H., H. Kataoka, J. Y. Meng, R. Hamasuna, N. Kitamura, and M. Koono. 2001. Mouse hepatocyte growth factor activator inhibitor type 1 (HAI-1) and type 2 (HAI-2)/placental bikunin genes and their promoters. Biochem. Biophys. Acta 1519:92–95.
   PubMedGoogle Scholar
• Itoh, H., H. Kataoka, M. Tomita, R. Hamasuna, Y. Nawa, N. Kitamura, and M. Koono. 2000. Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa. Am. J. Physiol. Gastrointest. Liver Physiol. 278:G635–G643.
   PubMed Web of Science ®Google Scholar
• Itoh, H., S. Naganuma, N. Takeda, S. Miyata, S. Uchinokura, T. Fukushima, S. Uchiyama, H. Tanaka, K. Nagaike, T. Shimomura, K. Miyazawa, G. Yamada, N. Kitamura, M. Koono, and H. Kataoka. 2004. Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice. Gastroenterology 127:1423–1435.
   PubMedGoogle Scholar
• Kataoka, H., J. Y. Meng, H. Itoh, R. Hamasuna, T. Shimomura, T. Suganuma, and M. Koono. 2000. Localization of hepatocyte growth factor activator inhibitor type 1 in Langhans' cells of human placenta. Histochem. Cell Biol. 114:469–475.
   PubMedGoogle Scholar
• Kataoka, H., R. Hamasuna, H. Itoh, N. Kitamura, and M. Koono. 2000. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma. Cancer Res. 60:6148–6159.
   PubMed Web of Science ®Google Scholar
• Kataoka, H., S. Miyata, S. Uchinokura, and H. Itoh. 2003. Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor. Cancer Metastasis Rev. 22:223–236.
   PubMed Web of Science ®Google Scholar
• Kataoka, H., T. Shimomura, T. Kawaguchi, R. Hamasuna, H. Itoh, N. Kitamura, K. Miyazawa, and M. Koono. 2000. Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator(HGFA) and regulates HGFA activity in the pericellular microenvironment. J. Biol. Chem. 275:40453–40462.
   PubMedGoogle Scholar
• Kataoka, H., T. Suganuma, T. Shimomura, H. Itoh, N. Kitamura, K. Nabeshima, and M. Koono. 1999. Distribution of hepatocyte growth factor activator inhibitor type 1(HAI-1) in human tissues: cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues. J. Histochem. Cytochem. 47:673–682.
   PubMedGoogle Scholar
• Kaufmann, M. H. 1992. Differentiation of the placenta, p. 472–477. In M. H. Kaufmann (ed.), The atlas of mouse development, 6th ed. Academic Press, Inc., New York, N.Y.
   Google Scholar
• Kawaguchi, T., L. Qin, T. Shimomura, J. Kondo, K. Matsumoto, K. Denda, and N. Kitamura. 1997. Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. J. Biol. Chem. 272:27558–27564.
   PubMed Web of Science ®Google Scholar
• Kirchhofer, D., M. Peek, W. Li, J. Stamos, C. Eigenbrot, S. Kadkhodayan, J. M. Elliot, R. T. Corpuz, R. A. Lazarus, and P. Moran. 2003. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1. J. Biol. Chem. 278:36341–36349.
   PubMedGoogle Scholar
• Lee, S. L., R. B. Dickson, and C. Y. Lin. 2000. Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J. Biol. Chem. 275:36720–36725.
   PubMed Web of Science ®Google Scholar
• Lescin, K. R., S. Varmuza, and J. Rossant. 1988. Isolation and characterization of a novel trophoblast-specific cDNA in the mouse. Genes Dev. 2:1639–1646.
   PubMedGoogle Scholar
• Lin, C. Y., J. Anders, M. Johnson, and R. B. Dickson. 1999. Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J. Biol. Chem. 274:18237–18242.
   PubMed Web of Science ®Google Scholar
• Lin, C. Y., J. Anders, M. Johnson, Q. A. Sang, and R. B. Dickson. 1999. Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. J. Biol. Chem. 274:18231–18236.
   PubMed Web of Science ®Google Scholar
• List, K., C. C. Haudenschild, R. Szabo, W. J. Chen, S. M. Wahl, W. Swaim, L. H. Engelholm, N. Behrend, and T. H. Bugge. 2002. Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene 21:3765–3779.
   PubMed Web of Science ®Google Scholar
• List, K., R. Szabo, P. W. Wertz, J. Segre, C. C. Haudenschild, S. Y. Kim, and T. H. Bugge. 2003. Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1. J. Cell Biol. 163:901–910.
   PubMed Web of Science ®Google Scholar
• Mitchell, K. J., K. I. Pinson, O. G. Kelly, J. Brennan, J. Zupicich, P. Scherz, P. A. Leighton, L. V. Goodrich, X. Lu, B. J. Avery, P. Tate, K. Dill, E. Pangilian, P. Wakenight, M. Tessier-Lavigne, and W. C. Skarnes. 2001. Functional analysis of secreted and transmembrane proteins critical to mouse development. Nat. Genet. 28:241–249.
   PubMedGoogle Scholar
• Miyazawa, K., T. Shimomura, A. Kitamura, J. Kondo, Y. Morimoto, and N. Kitamura. 1993. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. J. Biol. Chem. 268:10024–10028.
   PubMed Web of Science ®Google Scholar
• Miyazawa, K., T. Shimomura, and N. Kitamura. 1996. Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. J. Biol. Chem. 271:3615–3618.
   PubMedGoogle Scholar
• Moser, M., Y. Li, K. Vaupel, D. Kretzschmar, R. Kluge, P. Glynn, and R. Buettner. 2004. Placental failure and impaired vasculogenesis result in embryonic lethality for neuropathy target esterase-deficient mice. Mol. Cell. Biol. 24:1667–1679.
   PubMed Web of Science ®Google Scholar
• Nagaike, K., K. Kohama, S. Uchiyama, H. Tanaka, K. Chijiiwa, H. Itoh, and H. Kataoka. 2004. Paradoxically enhanced immunoreactivity of hepatocyte growth factor activator inhibitor type 1(HAI-1) in cancer cells at the invasion front. Cancer Sci. 95:728–735.
   PubMedGoogle Scholar
• Oberst, M. D., C. A. Williams, R. B. Dickson, M. D. Johnson, and C. Y. Lin. 2003. The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. J. Biol. Chem. 278:26773–26779.
   PubMed Web of Science ®Google Scholar
• Pavek, P., F. Staud, Z. Fendrich, H. Sklenarova, A. Libra, M. Novotna, M. Kopecky, M. Nobilis, and V. Semecky. 2003. Examination of the functional activity of P-glycoprotein in the rat placental barrier using rhodamine 123. J. Pharmacol. Exp. Ther. 305:1239–1250.
   PubMed Web of Science ®Google Scholar
• Pötgens, A. J. G., H. Kataoka, S. Ferstl, H. G. Frank, and P. Kaufmann. 2003. A positive immunoselection method to isolate villous cytotrophoblast cells from first trimester and term placenta to high purity. Placenta 24:412–423.
   PubMedGoogle Scholar
• Roberts, R. M., T. Ezashi, and P. Das. 2004. Trophoblast gene expression: Transcription factors in the specification of early trophoblast. Reprod. Biol. Endocrinol. 2:1–9.
   PubMedGoogle Scholar
• Rossant, J., and J. C. Cross. 2001. Placental development: lessons from mouse mutants. Nat. Rev. Genet. 2:538–548.
   PubMed Web of Science ®Google Scholar
• Schmidt, C., F. Bladt, S. Goedecke, V. Brinkmann, W. Zschiesche, M. Sharpe, E. Gherardi, and C. Birchmeler. 1995. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373:699–702.
   PubMed Web of Science ®Google Scholar
• Schreiber, J., E. Riethmacher-Sonnenberg, D. Riethmacher, E. E. Tuerk, J. Enderich, M. R. Bösl, and M. Wegner. 2000. Placental failure in mice lacking the mammalian homolog of glial cell missing. GCMa. Mol. Cell. Biol. 20:2466–2474.
   PubMed Web of Science ®Google Scholar
• Shimomura, T., K. Denda, A. Kitamura, T. Kawaguchi, M. Kito, J. Kondo, S. Kagaya, L. Qin, H. Takata, K. Miyazawa, and N. Kitamura. 1997. Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J. Biol. Chem. 272:6370–6376.
   PubMed Web of Science ®Google Scholar
• Takeuchi, T., J. L. Harris, W. Huang, K. W. Yan, S. R. Coughlin, and C. S. Craik. 2000. Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J. Biol. Chem. 275:26333–26342.
   PubMed Web of Science ®Google Scholar
• Uehara, Y., O. Minowa, C. Mori, K. Shiota, J. Kuno, T. Noda, and N. Kitamura. 1995. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373:702–705.
   PubMed Web of Science ®Google Scholar
• Voss, A. K., T. Thomas, and P. Gruss. 2000. Mice lacking HSP90βfail to develop a placental labyrinth. Development 127:1–11.
   PubMed Web of Science ®Google Scholar
• Yagi, T., T. Tokunaga, Y. Furuta, S. Nada, M. Yoshida, T. Tsukuda, Y. Saga, N. Takeda, Y. Ikawa, and S. Aizawa. 1993. A novel ES cell line, TT2, with high germline-differentiating potency. Anal. Biochem. 214:70–76.
   PubMed Web of Science ®Google Scholar
• Zhang, Y. W., and G. F. Vande Wounde. 2003. HGF/SF-Met signaling in the control of branching morphogenesis and invasion. J. Cell Biochem. 88:408–417.
   PubMed Web of Science ®Google Scholar